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Background: Hypertension remains one of the most common chronic conditions in the United 
States leading to several health complications and immense financial burdens, yet it remains 
grossly undertreated despite the availability of evidence-based treatment options. The 2017 
guidelines from the American College of Cardiology and American Heart Association 
recommended the use of home blood pressure monitoring with a telehealth component as an 
adjunct to regular hypertension treatment; however, implementing this into practice can be 
difficult depending on the setting, available resources, and the knowledge and skills of the 
providers. Aims: The purpose of this investigation is to evaluate patient adherence of measuring 
and logging blood pressure on the electronic medical record patient portal and the provider 
offering feedback regarding treatment. A secondary aim is to evaluate blood pressure trends of 
patients pre- and post-intervention. Methods: A retrospective and prospective study was 
completed to evaluate patient and provider adherence to using the recommended home blood 
pressure monitoring with telehealth transmission. The goal was for patients to take and log blood 
pressure daily for a minimum of two weeks. The number of blood pressures used to assess 
adherence was 12 blood pressures in a one-month period. The provider was expected to follow 
up anytime within the month period. Change in systolic and diastolic blood pressure was also 
assessed. Results: Nine patients met the inclusion criteria and all nine patients participated in the 
telehealth intervention. Six (66.7%) were adherent and logged at least 12 blood pressures, seven 
(77.8%) logged at least 11 blood pressures and two participants (22.2%) logged no blood 
pressure measurements. Provider feedback was given to the seven participants (77.8%) who 
logged data. All patients who logged blood pressure measurements were within goal or near goal 
at the end of the intervention. Discussion/Implications: High levels of provider and patient 





cointervention for the management of hypertension in the primary care setting and could be 
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Evaluating the Use of Telehealth to Manage Hypertension in the Primary Care 
Problem Statement/Background/Significance 
Uncontrolled hypertension remains a significant problem in the United States despite the fact 
that in most patients, this condition can be well-managed with lifestyle changes and 
pharmacological interventions. Untreated or undertreated hypertension can lead to devastating 
health consequences including death and puts a heavy burden on the healthcare system (Centers 
for Disease Control and Prevention [CDC], 2020). In 2020, almost one half of the adults in the 
United States had a diagnosis of hypertension; this has increased from one third of adults in 2016 
(CDC, 2016, 2020). Hypertension costs the U.S. about $131 billion each year from health care 
services, medications and missed days of work (CDC, 2020). Hypertension increases the risk for 
stroke and heart disease, the leading cause of death in the United States. Moreover, only about 
one half of adults with hypertension have attained blood pressure control (CDC, 2016). Barriers 
to successful management of hypertension include suboptimal medication dosage/therapy inertia 
(lack of medication changes after initial diagnosis and treatment was developed), lack of patient 
engagement, non-adherence to treatment recommendations and limited resources to educate 
patients on lifestyle changes (Milani et al., 2016). 
One factor that contributes to uncontrolled hypertension is under treatment or conservative 
management of hypertension by providers. This occurs for several reasons. For example, Mu and 
Mukamal (2016) found that some of these reasons may occur due to competing demands of 
primary care providers, a growing number of clinical practice guidelines with conflicting 





hypertension include previous visits with well-controlled blood pressure, side effects from 
medications, a patient’s informed decision declining the intensification of therapy and the 
initiation of lifestyle interventions. Mu and Mukamal (2016) found that in several ambulatory 
clinics across diverse demographics, providers rarely intensified antihypertensive therapy for 
patients with an elevated blood pressure. For a systolic blood pressure greater than 120 mm Hg, 
only 11% of patients received treatment intensification (9.7 million out of a potential 88.4 
million). A higher prevalence of intensification occurred for those with higher blood pressure. Of 
those with a systolic blood pressure greater than 160 mm Hg, only 2.5 million out of 9.7 million 
(25.2%) had treatment intensified. This indicates that patients with higher blood pressures were 
more likely to receive intensification of therapy but mild to moderately elevated blood pressures 
were not treated with such urgency. This potential treatment inertia can lead to devasting health 
outcomes. Timely intensification of medication may help improve hypertension-related 
morbidity and mortality nationwide (Mu & Mukamal, 2016). Recent research indicates that 
treatment intensification improves hypertension management even with suboptimal adherence 
with a reduction of cardiovascular events and deaths (Mu & Mukamal, 2016).   
Chronic illnesses require patient engagement to achieve maximum benefit and control of the 
condition. Patient engagement has been shown to be an indicator of high-quality care, lower cost, 
and better health. This has been shown to be dose dependent, i.e., the higher the engagement the 
better the outcomes (Kaplan et al, 2017). Telehealth can be used as an effective method to 
facilitate patient engagement. The Centers for Medicare and Medicaid Services’ (CMS) 
electronic health records (EHR) incentive program, “Meaningful Use” encourages the use of 
health information technology to promote patient engagement and provide a better understanding 





Telehealth is a broad term used to define healthcare provided remotely. There are four types 
of telehealth branches. Synchronous telehealth includes a video visit or live chat with the patient 
and provider. Care is provided in real time. Remote patient monitoring (RPM) allows providers 
to view data collected from the patient remotely, such as vital signs. This form of telehealth is 
often recommended for patients with chronic conditions. Asynchronous telehealth, or store-and-
forward, allows the transmission of patient health information to another healthcare provider. 
Mobile health, or mHealth, utilizes smart devices that can collect data about a person’s health 
(e.g., heart rate, pulse ox, movement tracking and sleep cycles) to promote healthy behaviors 
(Pennic, 2015). Often a combination of two or more types of telehealth are used to provide 
remote healthcare to patients. 
Out-of-office blood pressure monitoring is useful with a cointervention such as telehealth or 
counseling to diagnose and manage pharmacological therapy of hypertension (Whelton, 2017). 
The 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood 
Pressure in Adults gave a Grade I recommendation for the use of out-of-office blood pressure 
measurements to help confirm and titrate medications with telehealth counseling or clinical 
interventions. An additional Grade IIA recommendation was given on the use of telehealth 
strategies in addition to usual care intervention to reduce blood pressure in adults with 
hypertension (Whelton et al., 2017). The effects of various telehealth interventions for lowering 
blood pressure were significantly greater than blood pressure self-monitoring without 
transmission suggesting the importance of the teletransmission approach and timelier provider 
feedback. Telehealth has not been demonstrated to be an effective standalone strategy to manage 
hypertension; however, telehealth with cointerventions has been shown to be an effective adjunct 






 In a Northern Kentucky community hospital primary care clinic, a physician champion 
identified suboptimal control of hypertension as an important clinical problem. Specifically, the 
issue of patients who present with elevated blood pressure in the office but report their blood 
pressure is well controlled at home. This is reported as a common occurrence and presents a 
clinical dilemma of whether or not to intensify pharmacological therapy. The goal of this project 
was to develop and implement an evidence-based intervention to identify patients who have 
controlled hypertension versus those who have truly elevated blood pressure requiring 
intensification of pharmacological therapy and closer follow-up care. A preliminary review of 
the literature revealed that out-of-office blood pressure with a component of telehealth can be 
effective in managing hypertension. The goal was to pilot the implementation of home-blood 
pressure monitoring with the transmission of data using the MyChart® application, which is 
linked to Epic®, the electronic health records (EHR) system used by the facility, to assess 
adherence to daily blood pressure monitoring and logging the data in the EHR and gauge the 
potential feasibility of implementing this intervention. 
  The primary objective is to evaluate patient adherence to a regimen of taking and logging 
12 blood pressures in a 4-week period on the application and the provider offering feedback 
within that month regarding treatment. A secondary objective is to evaluate blood pressure trends 
among patients pre- and post-intervention. 
Theoretical Framework 
 The health belief model (HBM) was developed in the 1950s by social scientists at the 
United States Public Health Service to understand people’s failure to adopt disease prevention 





barriers and facilitators of adherence with recommended treatment (Rosenstock, 1974; LaMorte, 
2019). The six tenets of the HBM are perceived susceptibility, perceived severity, perceived 
benefits, perceived barriers, cues to action and self-efficacy (LaMorte, 2019). The HBM suggests 
that a person’s belief in the effectiveness of the recommended health behavior or action will 
predict the likelihood that the person will adopt the behavior. The HBM assumes that individuals 
have the desire to avoid illness, and the belief that a specific health action will prevent, or cure 
illness will influence their associated health behaviors. An individual’s response often depends 
on the person’s perception of the benefits and barriers of a health behavior (LaMorte, 2019).  
 This model was ideal for this project because of the nature of the intervention. Each tenet 
of the HBM was addressed to help maximize patient adherence to the intervention (figure 1). 
Home blood pressure monitoring and telehealth logging are largely patient dependent. Provider 
education with the patient focused on the severity of the uncontrolled condition as well as the 
long-term health effects. Patients might not fully understand the potential consequences of 
untreated or undertreated hypertension as they might not have any symptoms. Also, the use of 
the MyChart application allows a graph view (see Appendix A) for the patient to see how their 
blood pressure is trending. This allowed the patient to have a visual representation of their health 
which served as a cue to action. The education given by the physician champion focused on the 
patient’s perceived severity of the illness. Discussing the benefits of gaining control of 
hypertension with lifestyle changes and medication adherence was intended to help the patient 
focus on perceived benefits of controlling their hypertension with the use of home blood pressure 
monitoring and teletransmission of data. Education on how to perform the intervention, including 
the logging of blood pressure with the MyChart application was provided by a clinical 





hypertension. Blood pressure cuffs were also purchased by the clinic for patients to borrow, to 
help negate some of the financial burden of purchasing a blood pressure cuff.  
 This intervention was performed in the patient’s home which helped alleviate the 
potential barrier of setting up transportation and the financial cost of traveling to the clinic to 
obtain blood pressure readings. Cues to action are the stimulus needed to trigger a behavioral 
change (LaMorte, 2019). Patients might not perceive their blood pressure as a problem until the 
topic is brought up by a healthcare provider. Provider education and recommendation of a 
behavioral change acted as a cue to action. Seeing the trends and the improvement of logged 
blood pressure acted as a cue to action to sustain the changed behavior. The provider education 
helped address all six tenets of the health belief model to help the patients be successful with the 
self-management component of their hypertension. 
Review of Literature 
Method 
A literature review was conducted using PubMed, with search terms hypertension, 
uncontrolled, telehealth, primary care, and mhealth. Additional filters for data retrieval included: 
adults age 19+, English language and published between 2015 and 2020. Sixteen articles were 
identified using these search criteria. Abstracts were reviewed for relevance; eight articles were 
eliminated for irrelevance to the study topic. These included articles focused on diabetes and 
chronic kidney disease. Two more articles were eliminated because they were clinical trial 
protocols enrolling patients for future studies and had not collected data. Six articles were 





Synthesis of Evidence 
  Six articles were reviewed to assess the usefulness and feasibility of telehealth and 
technology with home blood pressure monitoring. Pan et al. (2018), Buis et al. (2020) and 
Sheppard et al. (2020) evaluated changes in clinic blood pressure pre- and post-home blood 
pressure telemonitoring. A significant reduction in both systolic and diastolic blood pressure was 
found in the intervention group. Even more significant was a high rate of adherence to the 
intervention in the study by Pan et al. (2020) with 86.5% of participants in the intervention group 
completing more than 70% of the required transmissions of their blood pressure reading. 
Similarly, Buis et al. (2020) found that participants uploaded at least one blood pressure on 75% 
of study days and 40.1% were fully compliant on days between baseline and follow-up. 
According to a systematic review by Sheppard et al. (2020) patient self-monitoring was 
associated with greater reduction in systolic blood pressure compared to usual care, regardless of 
hypertension-related comorbidities at 12 months. High intensity interventions were more 
effective than low intensity interventions in patients with obesity and stroke. High intensity 
interventions included self-monitoring with an active intervention, including web based or 
telephone tools to provide feedback, or self-monitoring with significant tailored support, from a 
clinician or pharmacist indicating the importance of patient and provider engagement. 
The Hyperlink trial conducted by Margolis et al. (2013) tested a 12-month intervention of 
home blood pressure with telemonitoring with pharmacist management in adults with 
uncontrolled hypertension which led to improved blood pressure control at six and twelve 
months. Beran et al. (2018) evaluated what contributed to the Hyperlink trial’s success. Focus 
groups from patients and an interview with the pharmacist found that the key components of 





frequent contact with the pharmacist. The frequent check-in with the pharmacist allowed for 
checkpoints to increase medication therapy and reinforce lifestyle modifications. Pan et al. 
(2018) also found that participants in the intervention group were more likely to receive 
medication changes than the control group, who received usual care (48.7% compared to 12.3%). 
Additional benefits of home blood pressure monitoring with telehealth transmission were 
increased patient awareness and involvement, as well as more data for the medical team which 
improves communication and coordination (Pan et al., 2018).  
  Perceived benefits and burdens of the use of digital self-management intervention used 
for reducing blood pressure were evaluated in a qualitative study conducted by Morton et al. 
(2018). Participants were asked open-ended questions and seven themes were identified. Some 
participants felt a benefit from seeing blood pressure readings, increased motivation for lifestyle 
modifications, and the benefit of better health after seeing the effects of medication and lifestyle 
changes. However, the participants also identified burdens of self-management including 
worrying about health, uncertainty about whether the readings were representative, the burden of 
making lifestyle changes and the burden of practicality (Morton et al., 2018). One limitation of 
the study was that an assessment of psychological factors such as reassurance, anxiety and 
uncertainty was not performed (Morton et al., 2018).  
The reliability and accountability of patients to truthfully report blood pressures readings 
without the use of automatic transmission may be a concern for providers when recommending 
this type of intervention. However, this does not seem to be a clinically significant concern. 
Parker et al. (2018) found a correlation of texted blood pressures having both an ending zero in 
the systolic and diastolic blood pressure when compared to the automatic transmitted blood 





Another finding was the preference for a systolic blood pressure of 134 and diastolic blood 
pressure of 84 when alert cut offs were 135/85. This occurred less than 4% of the time and was 
also not thought to be clinically significant. 
Identification of Knowledge Gap in Practice 
The effectiveness of telehealth interventions and home blood pressure monitoring has 
been established in the literature and is recommended in the 2017 guidelines from the American 
College of Cardiology and the American Heart Association to reduce blood pressure in 
hypertensive patients. What has not been well established is if this type of intervention works 
better for some patient populations than for others. It is important to determine whether age, 
technological experience, rural versus urban location or socioeconomic status affect the benefit 
of the intervention. Different demographic factors are important components to adherence; 
however, these were not evaluated in this investigation. 
The guideline reports uncertainty about which combinations of telehealth interventions 
work best such as auto transmission or, self-log. However, the key to success in all strategies was 
the timely provider follow-up and individualized care. 
Methods 
Project Design 
The project design was a retrospective and prospective study of patients who tracked 
home blood pressure using the MyChart application from August 1, 2020 to March 1, 2021 at a 
Northern Kentucky nonacademic community hospital primary care clinic. A chart review was 







The project was implemented at a community hospital primary care clinic in Northern 
Kentucky. There are four physicians working at the office. The physician champion typically 
treats twenty-two to thirty patients a day with visit duration ranging from ten to twenty minutes. 
Current workflow includes the medical assistant (MA) rooming patients and taking vital signs. 
The MA first takes an automatic blood pressure. If this blood pressure is elevated, the MA will 
then take a manual blood pressure. If this blood pressure is then elevated the MA will report the 
reading to the physician champion and the blood pressure will be rechecked at the end of the 
visit. Patients are currently being asked to use a paper log of blood pressures and bring it to each 
visit for review with the provider. 
Congruence of Project to Institutions Mission 
The hospital uses the model ICARE, which stands for Innovation, Collaboration, 
Accountability, Respect and Excellence to represent the core values of the healthcare institution. 
This project was congruent with the values of innovation, collaboration, and excellence. The 
project used technology as an innovative method to improve hypertension, a chronic condition, 
by using creative solutions recommended by current evidence-based guidelines to promote 
provider and patient accountability. The project used collaboration with the MD, Clinical 
Pharmacist, MA, and information technology (IT). The aim of this project was to provide the 
best care for the patient while encouraging patients and giving them the tools required to manage 





Stakeholders and a Description of their Roles in the Project 
The physician champion was a stakeholder in this project. The goal was to pilot the use 
of home blood pressure monitoring with data transmission with the ultimate goal of the entire 
practice utilizing telehealth management for improved blood pressure control. The physician 
champion was responsible for ordering home blood pressure monitoring for patients, making 
adequate adjustments to antihypertensive medication regimens and providing adequate follow up 
for patients.  
The MA was responsible for taking the initial blood pressure and subsequent blood 
pressures as needed when the patient was roomed. The clinical pharmacist was responsible for 
educating the patient how to accurately obtain a home blood pressure reading and how to log 
blood pressure in the MyChart application. The administrative staff was responsible for setting 
up patient appointments and ensuring follow-up. The information systems department provided 
education to the physician on how to activate the blood pressure tracking feature on the MyChart 
application and provided a tip sheet for patients to remind them of the steps of the process if 
needed.  
The patients were also stakeholders as hypertension is a chronic disease that requires 
patient participation to successfully manage. Patient buy-in was crucial as they were responsible 
for medication adherence and taking and recording their blood pressures.  
Site-specific Facilitators and Barriers to Implementation 
The CMS Meaningful Use Initiative requires the use of health information technology to 
promote patient engagement and communication of care. Encouraging patient and provider 
interaction as well as data transmission using the patient portal fills this measure. The clinic uses 





Blood pressure control is a quality indicator measured at the clinic for each provider. 
Gaining control of hypertensive patients who were previously uncontrolled would reflect 
positively on the provider’s care making the providers more willing to partake in the 
intervention.  
Another facilitator is the national clinical quality measure (CQMS), the Merit-Based 
Incentive Payment System (MIPS) from the CMS. The measure is to be submitted once per 
performance period (12 months) for patients with diagnosed hypertension. The most recent 
quality code is used to generate performance calculation. This creates national pressure to 
adequately control hypertension (CMS, 2019).  
As of 2020, providers are now able to bill for at home blood pressure monitoring creating 
an additional financial incentive. The current procedural guidelines now have two new currently 
procedural terminology (CPT) codes to support home blood-pressure monitoring (Berg, 2019). 
This acts as a financial incentive for providers to order home-blood pressure monitoring. One 
code will be for the initial education (99473) and the other code can be billed once a month for 
ongoing treatment decisions of reviewing the blood pressures (99474). To bill for this code, 28 
blood pressure readings over a 30-day period with a minimum of 12 readings is required and was 
chosen as the minimum goal for blood pressures recorded in one month (Berg, 2019).  
One of the largest barriers was achieving insurance coverage and patients obtaining blood 
pressure cuffs for home use. Some insurance plans do not cover home blood pressure monitoring 
devices therefore the patient would be expected to pay out-of-pocket for these monitors. The 
price range could be as little as $20 to over $100. Allowing the patient to borrow blood pressure 






The target population was adult patients over the age of 18 years of age with a known or 
new diagnosis of hypertension whose blood pressure was not currently within goal range. 
Inclusion criteria for patient participation were: adults 18 years and older, patients of the 
physician champion, above goal blood pressure at office visit, MyChart activated, and having an 
in-person appointment within the study period. Patients who met these criteria were approached 
by the physician about performing the intervention (table 2). Those who were agreeable were 
then given an order to check home blood pressure with telehealth transmission. The sample for 
the study included all patients of the physician champion who were recommended to check blood 
pressure at home and log the readings using the MyChart application. 
Procedure 
IRB Approval 
The study protocol was reviewed and approved as an exempt application by two 
institutional review boards at two separate institutions.  
Description of Evidence Based Intervention 
The evidence-based intervention assessed was the use of a telehealth strategy with home 
blood pressure monitoring. This study aimed to assess patient adherence to taking and logging 
home blood pressures using the MyChart application as well as adherence with provider follow-
up of readings and possible interventions. Adults with out of goal blood pressure who met the 
inclusion criteria were asked to check blood pressures at home and log the results in the MyChart 
applications for a minimum of two weeks but could continue up to one month. Those who were 
agreeable received education from the clinical pharmacist or MA on how to properly check 





placed in Epic enabling the patient flowsheet, which allowed blood pressure readings to be 
logged. Participants were asked to check blood pressure for a minimum of two weeks but could 
continue up to four weeks. By the end of the four weeks the provider would contact the patient 
via MyChart message to discuss plan of care such as to continue current therapy, increase 
medication, decrease medication, continue home blood pressure checks or to schedule an office 
visit. The follow up could be a telephone call, MyChart message, video visit or in person patient 
visit. Thresholds for extremely elevated or low blood pressures were set based on patient 
dependent risk and goals. Notifications would be sent through Epic to the provider if these 
triggers were meant to allow for early feedback and interventions. 
Measures and Instruments 
Measurement of patient blood pressure was recorded by the patients to assess the blood 
pressure trend. The number of blood pressures obtained by the patient in a two-week and four-
week period was evaluated as well as overall trends of systolic and diastolic blood pressure. 
Follow up by the provider was assessed using the chart review tab in Epic. Provider follow-up as 
well as intervention provided was assessed. 
Data Collection  
Data were collected by performing a chart review in Epic. The provider champion carbon 
copied all participants who were asked to perform the intervention to the DNP student allowing 
access to the medical chart. The data included the demographic data, blood pressures recorded by 
patients over two and four weeks, the number of blood pressures taken in the given cycle, the 
communication from the provider to the patient as well as documentation of the communication 
from the provider to the patient. Data was stored in a password protected program, RedCap and a 





Data Analysis Plan 
 Descriptive statistics were used to analyze demographic data as well as data collected to 
evaluate the intervention. Data was placed in tables and graphs using excel to identify trends in 
the data.   
Results 
Nine patients met the inclusion criteria and were approached about participation in the 
intervention. All nine patients approached were agreeable to participate in the intervention 
during the data collection period. Complete demographic data is in table 2. Of the participants, 
seven were male (77.8%) and two were female (22.2%). Age was well distributed between the 
age of 25 to 75 years and older. All nine participants (100%) were Caucasian. Most participants, 
five individuals, had some version of public health insurance (55.6%) while three had private 
(33.3%) and one participant had no health insurance (11.1%). Six (66.7%) of the patients were 
on hypertensive medication prior to the intervention. The majority of participants were classified 
as obese (7, 77.8%) and had a comorbid diagnosis of hyperlipidemia (5, 55.6%). Most were 
nonsmokers (6, 66.7%) and did not have a diabetes diagnosis (8, 88.9%)  
Evaluation of patient adherence to the interventions found that six participants (66.7%) 
completed a minimum of 12 blood pressures but only two participants (22.2%) completed 28 
blood pressure measurements (figure 3 and 4). One participant (11.1%) had logged eleven blood 
pressures over the period and two participants (22.2%) logged no data over the period. Of the 
seven patients (77.8%) who completed any number of blood pressure logs, all participants 
received feedback from the provider within four weeks (figure 7). Of the seven, four (57.1%) 





(14.3%) and two (28.9%) were recommended to make no changes to their current medication 
(figure 9).  
A trend noting decrease in both systolic and diastolic blood pressure was noted when 
each were plotted in a line graph. Participants who had medication dosages increased were noted 
to have logged more blood pressure readings (figure 5 and 6) than those who did not have 
medication increased. The trend of systolic and diastolic blood pressure indicates that all patients 
had controlled or near controlled blood pressure by the end of the evaluation. Statistical analyses 
were not possible due to the small sample sizes. 
Discussion  
 This investigation found high rates of adherence to blood pressure monitoring and 
logging as well as timely provider feedback. When looking at the primary objective of patients 
and provider adherence to taking blood pressure and logging, both patient and provider had high 
rates of adherences (figure 3 and 4). Overall patients were highly adherent to the intervention of 
taking and logging blood pressure with seven of the nine (77.8%) participants logging any 
amount of blood pressure and six (66.7%) logging the minimum of 12 blood pressures during the 
data collection period. Only two participants (22.2%) logged at least 28 blood pressure readings 
over the collection period. These results are consistent with other similar studies from Buis et al 
(2020) and Pan et al (2018) who also found high rates of adherence to monitoring home blood 
pressure and electronically logging blood pressure data.  
This investigation found that younger participants were less likely to log blood pressure. 
Age (35-44 years old) was the only similarity between the two participants who did not log any 
blood pressure readings. This could have occurred for a variety of reason but may have occurred 





perceive elevated blood pressure as a concern. This is consistent with the results from Ma (2018) 
which found age was associated with differing self-care behaviors; middle-aged adults had better 
self-care behaviors than their younger counterparts. Future investigation should focus on age 
based perceived susceptibility and severity to assess if this link exists. Of the two participants 
with no logged blood pressures, one was male and on two antihypertensive medications and the 
other was female not on any medications.  
All patients who participated in the study were Caucasian. This, however, is reflective of 
the population of the county of this primary care clinic. In 2019, 94% of the county population 
was Caucasian and 3% was Black or African American (The United States Census Bureau, 
2019). This may be indicative that the intervention might not be effective for other demographic 
populations.   
 The wide range of ages of participants (table 3) of the study indicates that even with 
requirement of a smart phone and internet connection this intervention would be feasible for all 
ages. Technology did not likely play a large role in the intervention as patients were already 
enrolled in MyChart and had access to the internet with a smartphone prior to the intervention. 
Most patients are already enrolled in MyChart. Of the 2500 of the physician champions patients, 
1932 (77.3%) are currently registered for the MyChart, indicating this intervention would be 
appropriate for most patients.  
All seven patients who logged blood pressure received feedback from the provider (figure 
7). After the initial feedback using MyChart messages, a variety of methods were used including 
additional MyChart messages, video visits and in person visits. A combination of methods were 
used for some patients. Patients and providers appeared to favor some component of MyChart 





having to schedule an appointment or travel as frequently. This investigation only assessed the 
provider feedback within the month period but did not assess the time between provider feedback 
and intervention. Future studies should exam the length of time between each interactions as well 
as if those with higher levels of uncontrolled hypertension had more interaction between the 
provider.  
When discussing with the physician champion he noted the intervention was easy to use 
and easily integrated into current clinic workflow. One benefit of the intervention was the blood 
pressures were automatically integrated into the EHR. He noted that the intervention helps keep 
patients accountable for their health but also helps to better guide treatment for these patients.  
Changes in systolic and diastolic blood pressure was evaluated as well (figure 5 and 6). A 
reduction of both systolic and diastolic blood pressure was noted from the beginning to the end 
of the sample period. These results are consistent with prior studies from Pan et al. (2018), Buis 
et al. (2020) and Sheppard et al. (2020) who found that self-monitoring with electronic logging 
was an effective method to reduce systolic and diastolic blood pressure. It was noted that those 
requiring medication increases had a greater reduction than those who did not require medication 
increases. This was likely due to these participants having higher systolic and diastolic blood 
pressures requiring medication intensifications which was then reflective in the blood pressure 
after the medication changes were made. These participants also logged more blood pressures 
which likely was a result of the change in the plan of care and the desire to see the change in 
blood pressure readings. This investigation indicates that home blood pressure monitoring and 
telehealth logging is a successful cointervention to usual care, however, it should be noted that 





This study did not evaluate the attitudes and feelings towards home blood pressure 
monitoring with a telehealth component, however this is an important factor for patient 
adherence. Morton et al., (2018) found that patients had mixed views on the use of self-blood 
pressure monitoring. Some patients found a benefit of performing the intervention as they felt it 
was beneficial to leading to better health and motivated them to make lifestyle changes. Other 
participants felt a perceived burden to self-monitoring and logging as they worried about their 
health. These attitudes and feelings toward the intervention may have been a contributor to 
patient participation in this investigation and should be studies in future studies.  
As a result of this investigation the physician champion has continued this intervention 
on other hypertensive patients to use this as a cointervention to usual care. He plans to share data 
collected from his patients as well as provide education on how to implement home blood 
pressuring measurement with a telehealth component. The ultimate plan is to implement this 
intervention office wide to all providers.   
Implications 
 This pilot study shows promising evidence to suggest that the use of telehealth 
intervention in addition to usual care can be effectively implemented with high levels of patient 
and provider adherence for the management of hypertension in this clinical setting. 
Implementation of this intervention practice wide would likely be beneficial however conducting 
a longitudinal study with a much larger sample size would yield more robust evidence regarding 
patient and provider adherence to the intervention as well as changes in blood pressure. Future 
investigations should also focus on long-term control of patient blood pressure in clinic. Further 
evaluation on different demographic variables such as age and gender, financial status and 





determine if certain education techniques work better for different populations. This 
investigation did not assess these factors. Further assessment of patient and provider preference 
on preferred feedback would be helpful in determining telehealth strategies to ensure tailored 
intervention and sustained patient engagement.  
 Future studies should focus on patient and provider attitudes toward the intervention to 
determine potential barriers to the use of home blood pressure monitoring with a telehealth 
component. This would help with understanding widespread application of the intervention to 
different clinical settings. 
Limitations 
 Several limitation to this study can be identified. First, the small sample size of the 
participants. All nine patients approached were agreeable to participate. Due to the small sample 
size inferential statistics could not be used to detect significance. The small sample may not be 
reflective of a larger population of patients. This study only evaluated Caucasian individuals and 
may not be reflective of other population groups. Contributing factors to the small sample size 
include using patients of only one provider and the COVID-19 pandemic. During the pandemic 
patients may have opted not to have in-person visits or follow-ups and the length of recruitment 
and may have favored video visits. Due to one of the pieces of inclusion criteria being the initial 
visit being in person this may have eliminated potential participants to the study.  
 Secondly, the Hawthorne effect may also have contributed to the high amount of patient 
adherence. Patients were aware that the provider was closely observing their blood pressures 
which may have increased patient adherence to measuring and logging blood pressures as well as 
medications and lifestyle changes which would have reflected in the blood pressure readings. 





However, Sheppard et al. (2020) found sustained blood pressure control at 12 months with the 
home blood pressure measurement and telehealth logging suggesting that this intervention is 
sustainable. Future longitudinal studies should focus on the sustained control of blood pressure in 
these patients at each clinical visit.  
Thirdly, only patients with uncontrolled hypertension were included. It would have been 
beneficial to include all patients who had a diagnosis of hypertension to evaluate out of office 
control of blood pressure.  
Conclusion 
 Hypertension is a treatable chronic condition but has high levels of suboptimal control 
nationwide (CDC, 2020). Uncontrolled hypertension can lead to high levels of mortality, 
morbidity and financial strain in the U.S. Several factors contribute to low levels of control 
including overly conservative treatment by providers, lack of patient engagement but also 
patients reporting out of office control of blood pressure (CDC, 2020). Patient’s reporting-
controlled blood pressure at home creates a clinical dilemma. The goal of this investigation was 
to implement an evidenced based intervention to assess blood pressure control to help guide 
treatment. The published evidence and clinical practice guidelines make recommendations to use 
home blood pressure monitoring with a telehealth component to increase patient engagement and 
out of office blood pressure measurements to direct care of hypertensive patients. A retrospective 
and prospective study was completed to evaluate the primary objective of assessing patient and 
provider adherence to the intervention as well as the secondary objective of improvement of 
systolic and diastolic blood pressure. Nine patients participated in the study with high levels of 
both patient and provider adherence to the intervention. The trend of systolic and diastolic blood 





adherence to the intervention as well as improved systolic and diastolic blood pressure suggest 
this intervention was an acceptable and feasible cointervention for the management of 
hypertension in the primary care. Further research should be done with larger sample sizes to 
confirm these results, assess the effects of different demographic variables as well as to evaluate 
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Table 1  
Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
Adults 18 and older 
Patients of the physician champion 
Above goal BP at office visit 
MyChart activated  
Appointment within study period 
Initial in-person visit 






















































Descriptive summary of participant characteristics (N = 9) 
Characteristics n (%) 
Age  
   18-24 years old 
   25-34 years old 
   35-44 years old 
   45-54 years old 
   55-64 years old 
   65-74 years old 










   Male 





   White 
   Hispanic or Latino 
   Black or African American 
   Native American or American Indian 







Type of Health Insurance 
   Private 
   Public 






   Single, never married 
   Married or domestic partnership 
   Widowed 
   Divorced 








   Yes 





   Yes 





   Yes 





   Yes 




Hypertensive Medication Prior 
   Yes 
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Objectives 
Evaluate the effect of home blood 
pressure monitoring with telehealth 
transmission on the control of high 




Average change in 
BP 
BP estimates on day 
30, 90 and 180 
Sample 
Intervention: n=52 
Control: n= 55 
Results/Findings 
-86.5% in the intervention group completed more than 
70% of required data transmission. 
-Medication changes 48.7% vs 12.3% 
-Greater reduction in blood pressure compared to 
control 
-Intervention greater reduction of BP 
-Higher use of app greater reduction 
-Increases patient awareness and involvement 
-Provides the medical team more data increasing 
medication changes 
-Improves communication and coordination 
Strength/Weaknesses 




-Long term effect not 
known 
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Objectives 
Investigate the feasibility, 
acceptability and preliminary 
effectiveness of BPTrack (a clinical 
pharmacist-led intervention that 
incorporates patient and clinician 
facing apps to make electronically 
collected, patient generated data 
availability to providers in real time 
for HTN management. App includes 
medication reminders. 
-Aimed to understand barriers to 
adoption and areas for improvement 
identified by key stakeholders in 










-change in BP 












-40.1% were fully compliant on days between 
baseline and follow-up. 
-After 12 weeks significantly reduce in SBP and DBP 
-Patient perceived it as effective 
-Medication reminder did not improve adherence 
-Patients uploaded at least one blood pressure 
measurement on 75% of study days 
-Reduction of SBP and DBP 











monitoring can reduce 



















-Change in clinic BP 
between baseline and 12 




uncontrolled BP at 12 
months by number of 
comorbidities  
 
Outcomes were also 
accessed at 6 months 
Sample 







were available in 
16 studies and 




Self-monitoring was associated with reduced clinic SBP 
compared to usual care at 12 month follow up regardless of 
comorbidities  
-Intense intervention were more effective than low intensity 
intervention in patients with obesity a possibly stroke but this 
effect was not observed in patients with CAD, DM or CKD 
-Self monitoring was found to be effective at lowering BP 
regardless of number of comorbidities  
-cointerventions include self-management, pharmacist 
support, tailored education and lifestyle counseling 
Strength/Weaknesses 
-Largest IPD meta-
analysis of trials 
examining the efficacy 
of self-monitoring of BP 
in HTN patients with a 
HTN related co-
morbidity  
-Unable to collect data 
from all related studies 
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Objectives 
Explore perceived 
burdens and benefits for 
patients using a digital 
self-management 
intervention for reducing 
high BP 
 
Further understand how to 
best capture burdens and 











1) Benefit of reassurance from seeing BP readings 
  -Reassurance when BP readings are well controlled 
  -Reassurance from keeping an eye on BP 
2) Benefit of motivation for lifestyle change from seeing BP 
readings 
  -Seeing BP readings motivated lifestyle change 
3) Benefit of better health 
  -Perceived health improvement from medication changes 
  -Intervention can facilitate management of side effects 
4) Burden of worrying about health 
  -Negative emotional responses to seeing high readings 
  -Worrying about medication change affecting health 
5) Burden of uncertainty from self-monitoring  
  -Uncertain about whether readings are representative 
  -Uncertainty about what to do about high or low readings 
6) Burden of thinking about making lifestyle changes 
  -Worry or guilty about not engaging with healthy changes 
7) Burden of the practicalities of adhering to intervention 
procedures 










-Repeated interview may 
have been helpful 
-Did not assess 
psychological factors 
such as reassurance, 
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Objectives 
The Hyperlink trial tested 
a 12-month intervention 
of home blood pressure 
telemonitoring with 
pharmacist case 
management in adults 
with uncontrolled 
hypertension. The 
intervention resulted in 
improved BP control 
compared with usual care 
at both 6 and 12 months. 
















of process of care data, 




patient of the 450 
were examined. 5 
patient focus 




The original study showed improvement in both SBP and 
DBP  
 
4 Themes Identified: 
-Relationship between patient and pharmacist 
-Individual Treatment plan 
-Communication between clinical staff 
-Importance of frequent phone contact with pharmacist 
 
BP control was achieved in 3 months in many patients 
-Key components of the intervention success were use of 
home monitor and frequent medication changes over the 
phone 
-Patient and pharmacist valued strong patient/pharmacist 
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Objectives 
To determine if there was 
an apparent preference for 
particular end digits and 
entries which were just 
below target BPs which 






Compare BP readings 
between the patient texts 
and automatic-
transmission systems 
while taking into account 







BP from 199 
Results/Findings 
Compared with automatic transmission, texted BPs had a 
significantly higher proportion of occurrences of both SBP 
and DBP having zero as an ending digit (less than 2%) 
Preference for SBP 134 and DBP 84 when alert cut off was 
135/85 
End zero preferences for zero numbers and specific value 
preferences for readings just below the alert threshold exist 
among self-reported data.  




-Large sample size 
-control group 
 
